Andy, adinarayana (35 résultats)

- Couverture souple
Vendeur : California Books, Miami, FL, Etats-UnisCalifornia Books
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 254,50
EUR 2,74 expéditionExpédition nationale : Etats-UnisQuantité disponible : Plus de 20 disponibles
Etat : New.

- Couverture souple
Vendeur : California Books, Miami, FL, Etats-UnisCalifornia Books
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 277,98
EUR 2,74 expéditionExpédition nationale : Etats-UnisQuantité disponible : Plus de 20 disponibles
Etat : New.

- Couverture souple
Vendeur : Rarewaves.com USA, London, LONDO, Royaume-UniRarewaves.com USA
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 289,79
Frais de port gratuitsExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : Plus de 20 disponibles
Paperback. Etat : New.

- Couverture rigide
Vendeur : California Books, Miami, FL, Etats-UnisCalifornia Books
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 301,46
EUR 2,74 expéditionExpédition nationale : Etats-UnisQuantité disponible : Plus de 20 disponibles
Etat : New.

- Couverture rigide
Vendeur : California Books, Miami, FL, Etats-UnisCalifornia Books
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 324,93
EUR 2,74 expéditionExpédition nationale : Etats-UnisQuantité disponible : Plus de 20 disponibles
Etat : New.

- Couverture rigide
Vendeur : Rarewaves.com USA, London, LONDO, Royaume-UniRarewaves.com USA
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 335,68
Frais de port gratuitsExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : Plus de 20 disponibles
Hardback. Etat : New.

- Couverture souple
Vendeur : Rarewaves.com UK, London, Royaume-UniRarewaves.com UK
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 280,07
EUR 77,55 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : Plus de 20 disponibles
Paperback. Etat : New.

- Couverture rigide
Vendeur : Rarewaves.com UK, London, Royaume-UniRarewaves.com UK
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 326,65
EUR 77,55 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : Plus de 20 disponibles
Hardback. Etat : New.

- Couverture rigide
Vendeur : Home-set, Mannheim, AllemagneHome-set
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 372,25
EUR 60,98 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : 2 disponibles
Gebundene Ausgabe. Etat : Neu. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. Sprache: Englisch Gewicht in Gramm: 1119.…

- Couverture rigide
Vendeur : Home-set, Mannheim, AllemagneHome-set
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 396,75
EUR 61,66 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : 2 disponibles
Gebundene Ausgabe. Etat : Neu. Artificial intelligence (AI) and machine learning (ML) transform drug research and personalized medicine by enabling faster, more precise, and data-driven approaches to healthcare. By analyzing complex datasets, AI-driven models can identify drug targets, predict interactions, and optimize drug development timelines. These technologies pave the way for personalized medicine, allowing treatments to be tailored to individuals' health. Together, AI and machine learning revolutionize how medicines are discovered, developed, and delivered, offering more effective therapies and improved patient outcomes. Revolutionizing Drug Research and Personalized Medicine Through AI and Machine Learning examines the effects of AI and ML on the pharmaceutical sector. It explores how intelligent technologies transform traditional drug research and development, highlighting their importance in personalized treatment methods. This book covers topics such as molecular design, phytochemicals, and vaccine development, and is a useful resource for engineers, medical and healthcare professionals, academicians, researchers, and scientists. Sprache: Englisch Gewicht in Gramm: 1188.…

- Couverture souple
- impression à la demande
Vendeur : Chiron Media, Wallingford, Royaume-UniChiron Media
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 202,95
EUR 7,74 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 20 disponibles
PF. Etat : New. This item is printed on demand. Brand new book, sourced directly from publisher. Dispatch time is 6-7 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.

- Couverture souple
- impression à la demande
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-UniPBShop.store UK
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 206,55
EUR 7,00 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : Plus de 20 disponibles
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Couverture souple
- impression à la demande
Vendeur : PBShop.store US, Wood Dale, IL, Etats-UnisPBShop.store US
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 220,31
Frais de port gratuitsExpédition nationale : Etats-UnisQuantité disponible : Plus de 20 disponibles
PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Couverture souple
- impression à la demande
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-UniPBShop.store UK
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 234,35
EUR 8,07 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : Plus de 20 disponibles
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Couverture souple
- impression à la demande
Vendeur : PBShop.store US, Wood Dale, IL, Etats-UnisPBShop.store US
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 249,58
Frais de port gratuitsExpédition nationale : Etats-UnisQuantité disponible : Plus de 20 disponibles
PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Couverture rigide
- impression à la demande
Vendeur : Chiron Media, Wallingford, Royaume-UniChiron Media
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 240,60
EUR 11,92 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 20 disponibles
Etat : New. This item is printed on demand. Brand new book, sourced directly from publisher. Dispatch time is 6-7 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.

- Couverture rigide
- impression à la demande
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-UniPBShop.store UK
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 244,05
EUR 8,07 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : Plus de 20 disponibles
HRD. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Couverture souple
- impression à la demande
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-UnisGrand Eagle Retail
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 255,45
Frais de port gratuitsExpédition nationale : Etats-UnisQuantité disponible : 1 disponible
Paperback. Etat : new. Paperback. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

- Couverture rigide
- impression à la demande
Vendeur : PBShop.store US, Wood Dale, IL, Etats-UnisPBShop.store US
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 260,55
Frais de port gratuitsExpédition nationale : Etats-UnisQuantité disponible : Plus de 20 disponibles
HRD. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Couverture souple
- impression à la demande
Vendeur : CitiRetail, Stevenage, Royaume-UniCitiRetail
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 216,87
EUR 44,14 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 1 disponible
Paperback. Etat : new. Paperback. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

- Couverture rigide
- impression à la demande
Vendeur : Chiron Media, Wallingford, Royaume-UniChiron Media
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 269,97
EUR 11,92 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 20 disponibles
Etat : New. This item is printed on demand. Brand new book, sourced directly from publisher. Dispatch time is 6-7 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.

- Couverture rigide
- impression à la demande
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-UniPBShop.store UK
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 273,39
EUR 8,07 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : Plus de 20 disponibles
HRD. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Couverture rigide
- impression à la demande
Vendeur : PBShop.store US, Wood Dale, IL, Etats-UnisPBShop.store US
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 291,45
Frais de port gratuitsExpédition nationale : Etats-UnisQuantité disponible : Plus de 20 disponibles
HRD. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

- Couverture souple
- impression à la demande
Vendeur : CitiRetail, Stevenage, Royaume-UniCitiRetail
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 245,76
EUR 44,14 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 1 disponible
Paperback. Etat : new. Paperback. Artificial intelligence (AI) and machine learning (ML) transform drug research and personalized medicine by enabling faster, more precise, and data-driven approaches to healthcare. By analyzing complex datasets, AI-driven models can identify drug targets, predict interactions, and optimize drug development timelines. These technologies pave the way for personalized medicine, allowing treatments to be tailored to individuals' health. Together, AI and machine learning revolutionize how medicines are discovered, developed, and delivered, offering more effective therapies and improved patient outcomes. Revolutionizing Drug Research and Personalized Medicine Through AI and Machine Learning examines the effects of AI and ML on the pharmaceutical sector. It explores how intelligent technologies transform traditional drug research and development, highlighting their importance in personalized treatment methods. This book covers topics such as molecular design, phytochemicals, and vaccine development, and is a useful resource for engineers, medical and healthcare professionals, academicians, researchers, and scientists. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

- Couverture rigide
- impression à la demande
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-UnisGrand Eagle Retail
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 298,34
Frais de port gratuitsExpédition nationale : Etats-UnisQuantité disponible : 1 disponible
Hardcover. Etat : new. Hardcover. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

- Couverture rigide
- impression à la demande
Vendeur : CitiRetail, Stevenage, Royaume-UniCitiRetail
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 255,59
EUR 44,14 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 1 disponible
Hardcover. Etat : new. Hardcover. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

- Couverture souple
- impression à la demande
Vendeur : AussieBookSeller, Truganina, VIC, AustralieAussieBookSeller
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 276,38
EUR 33,74 expéditionExpédition depuis Australie vers Etats-UnisQuantité disponible : 1 disponible
Paperback. Etat : new. Paperback. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

- Couverture rigide
- impression à la demande
Vendeur : CitiRetail, Stevenage, Royaume-UniCitiRetail
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 286,31
EUR 44,14 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 1 disponible
Hardcover. Etat : new. Hardcover. Artificial intelligence (AI) and machine learning (ML) transform drug research and personalized medicine by enabling faster, more precise, and data-driven approaches to healthcare. By analyzing complex datasets, AI-driven models can identify drug targets, predict interactions, and optimize drug development timelines. These technologies pave the way for personalized medicine, allowing treatments to be tailored to individuals' health. Together, AI and machine learning revolutionize how medicines are discovered, developed, and delivered, offering more effective therapies and improved patient outcomes. Revolutionizing Drug Research and Personalized Medicine Through AI and Machine Learning examines the effects of AI and ML on the pharmaceutical sector. It explores how intelligent technologies transform traditional drug research and development, highlighting their importance in personalized treatment methods. This book covers topics such as molecular design, phytochemicals, and vaccine development, and is a useful resource for engineers, medical and healthcare professionals, academicians, researchers, and scientists. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

- Couverture souple
- impression à la demande
Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 294,43
EUR 35,00 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : 2 disponibles
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more.…

- Couverture souple
- impression à la demande
Vendeur : preigu, Osnabrück, Allemagnepreigu
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 275,60
EUR 70,00 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : 5 disponibles
Taschenbuch. Etat : Neu. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies | Divya Andy (u. a.) | Taschenbuch | Englisch | 2026 | IGI GLOBAL SCIENTIFIC PUBLISHING | EAN 9798260001622 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. …